ATTENTION ALL CUSTOMERS: Due to a recent change of our website, the process for submitting refill requests online has now changed. Please click on “Sign Up Today!†to create a new account, and be sure to download our NEW Mobile app! Thank you for your patience during this transition
The National Institutes of Health (NIH) has stopped canceling biomedical research grants after a federal judge said hundreds of those cuts were illegal.
This decision comes just days after U.S. District Judge William Young ordered the NIH to restore more than 900 canceled grants. The ruling stemmed from a Boston case, in which re...
The National Institutes of Health (NIH) will fund studies of the long-term health effects of a 2023 Ohio train derailment that released more than 1 million pounds of hazardous chemicals into the soil, air and water.
Residents of East Palestine, Ohio, where the derailment occurred, have pressed the government to do more to answer questions about the mental and physical health effects of th...
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he may no longer allow government scientists to publish research in top medical journals.
Kennedy made the statement on a podcast called The Ultimate Human where he...
Dozens of staff at the U.S. National Institutes of Health (NIH) walked out of a recent town hall meeting after Director Dr. Jay Bhattacharya suggested the agency may have helped fund research that caused the COVID-19 pandemic.
Some of the nation's top brain researchers are still facing layoffs, even after U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. said no working scientists would be cut.
Last month, scientists at the National Institute of Neurological Disorders and Stroke (NINDS) got layoff notices. NINDS is part of...
The National Institutes of Health (NIH) is cutting or canceling more than 40 grants focused on vaccine hesitancy and ways to increase vaccine acceptance, according to an email obtained by The Washington Post.
The message -- sent Monday by Michelle Bulls, director of the Office of Policy for Extramural Research Admini...
Dr. Francis Collins, the famed geneticist who led the National Institutes of Health (NIH) for 12 years and helped guide the U.S. through the COVID pandemic, has stepped down.
Collins, who's 74, announced his retirement over the weekend, praising the NIH staff in a parting statement while offering what appeared to be a mes...
A federal judge has temporarily blocked the National Institutes of Health (NIH) from making big cuts in medical research funding ordered by the Trump administration.
The proposed cost-cutting could have reduced support for hospitals, universities and labs across the country.
More than 155,000 people who have taken part in a massive genetic study orchestrated by the U.S. National Institutes of Health (NIH) have already gotten something in return -- personalized DNA results that tell them whether they have an increased risk for certain health conditions.
Called "All of Us," the study aims to eventually include at least 1 million people, in an effort to accelera...
Dr. Anthony Fauci, who has advised seven presidents and spent more than five decades at the U.S. National Institutes of Health, will step down in December to "pursue the next chapter" of his career, he announced Monday.
There are two ways that HIV patients' bodies can keep the virus under control after they stop antiretroviral therapy, a new study shows.
The findings could point to ways to help people with HIV keep the virus in remission without having to keep taking medications that can have long-term side effects, according to researchers at the U.S. National Institute of Allergy and Infectious Disease...
Dr. Francis Collins, the longest serving director of the U.S. National Institutes of Health, plans to step down from his leadership post by the end of the year, the institute plans to announce on Tuesday.
Collins headed the government's effort to map the entire human genetic code 20 years ago, and he is now one of the most respected public health leaders in this country's battle against t...
Early treatment with COVID-19 survivors' blood plasma doesn't prevent disease progression in people who have mild COVID-19 symptoms but are at risk for more severe illness, a new clinical trial finds.
"As physicians, we wanted this to make a big difference in reducing severe illness and it did not," said principal investigator Dr. Clifton Callaway, professor of emergency medicine at the U...
